Merz closes acquisition of Onmel nail antifungal treatment
Merz Inc. has completed its purchase of Stiefel Labs’ Onmel, a tablet for treating toenail fungal infections. Merz said Tuesday that Onmel is the only Food and Drug Administration-approved oral treatment dosed in a once-daily, 200-mg single tablet of itraconazole.